Bionics Co., Ltd is a leading biotechnology company that was founded in 1998 with the mission of contributing to the improvement of human welfare and focusing on customer value realization. With over 20 years of experience and a commitment to continuous technological development and quality management, Bionics has become a powerhouse in the field of genetic synthesis and analysis services. In addition to their core services of gene synthesis and genetic analysis, Bionics has expanded into various other business areas such as cloning services, contract research and development (CRO), in vitro diagnostics, and direct-to-consumer (DTC) services.

They actively participate in collaborations with domestic institutions and academia, and they are dedicated to expanding into international markets and securing a global footprint. Bionics acknowledges that biotechnology is a crucial industry that will shape the future, from human health to the environment and food. Therefore, they are committed to continuous innovation and growth, aiming to lead the biotechnology industry with their differentiated core technology, product and service development, and the localization of the biological material industry with global competitiveness.

Their ultimate goal is to become a top-tier company that contributes to human welfare and impresses customers with cutting-edge biotechnology. Thank you for visiting Bionics Co., Ltd